308 related articles for article (PubMed ID: 28855340)
41. CDK8 and CDK19 regulate intestinal differentiation and homeostasis via the chromatin remodeling complex SWI/SNF.
Dannappel MV; Zhu D; Sun X; Chua HK; Poppelaars M; Suehiro M; Khadka S; Lim Kam Sian TC; Sooraj D; Loi M; Gao H; Croagh D; Daly RJ; Faridi P; Boyer TG; Firestein R
J Clin Invest; 2022 Oct; 132(20):. PubMed ID: 36006697
[TBL] [Abstract][Full Text] [Related]
42. Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer.
Serrao A; Jenkins LM; Chumanevich AA; Horst B; Liang J; Gatza ML; Lee NY; Roninson IB; Broude EV; Mythreye K
Oncogene; 2018 Aug; 37(35):4792-4808. PubMed ID: 29780169
[TBL] [Abstract][Full Text] [Related]
43. CDK8 and CDK19 act redundantly to control the CFTR pathway in the intestinal epithelium.
Prieto S; Dubra G; Camasses A; Aznar AB; Begon-Pescia C; Simboeck E; Pirot N; Gerbe F; Angevin L; Jay P; Krasinska L; Fisher D
EMBO Rep; 2023 Feb; 24(2):e54261. PubMed ID: 36545778
[TBL] [Abstract][Full Text] [Related]
44. Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities.
Porter DC; Farmaki E; Altilia S; Schools GP; West DK; Chen M; Chang BD; Puzyrev AT; Lim CU; Rokow-Kittell R; Friedhoff LT; Papavassiliou AG; Kalurupalle S; Hurteau G; Shi J; Baran PS; Gyorffy B; Wentland MP; Broude EV; Kiaris H; Roninson IB
Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13799-804. PubMed ID: 22869755
[TBL] [Abstract][Full Text] [Related]
45. A kinase subunit of the human mediator complex, CDK8, positively regulates transcriptional activation.
Furumoto T; Tanaka A; Ito M; Malik S; Hirose Y; Hanaoka F; Ohkuma Y
Genes Cells; 2007 Jan; 12(1):119-32. PubMed ID: 17212659
[TBL] [Abstract][Full Text] [Related]
46. Suppression of Mediator is regulated by Cdk8-dependent Grr1 turnover of the Med3 coactivator.
Gonzalez D; Hamidi N; Del Sol R; Benschop JJ; Nancy T; Li C; Francis L; Tzouros M; Krijgsveld J; Holstege FC; Conlan RS
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2500-5. PubMed ID: 24550274
[TBL] [Abstract][Full Text] [Related]
47. Discovery of
Wang M; Lin R; Li J; Suo Y; Gao J; Liu L; Zhou L; Ni Y; Yang Z; Zheng J; Lin J; Zhou H; Luo C; Lin H
J Med Chem; 2023 Apr; 66(7):4932-4951. PubMed ID: 36930701
[TBL] [Abstract][Full Text] [Related]
48. Discovery and Development of Cyclin-Dependent Kinase 8 Inhibitors.
Lv X; Tian Y; Li S; Cheng K; Huang X; Kong H; Liao C; Xie Z
Curr Med Chem; 2020; 27(32):5429-5443. PubMed ID: 30947649
[TBL] [Abstract][Full Text] [Related]
49. Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells.
Johannessen L; Sundberg TB; O'Connell DJ; Kolde R; Berstler J; Billings KJ; Khor B; Seashore-Ludlow B; Fassl A; Russell CN; Latorre IJ; Jiang B; Graham DB; Perez JR; Sicinski P; Phillips AJ; Schreiber SL; Gray NS; Shamji AF; Xavier RJ
Nat Chem Biol; 2017 Oct; 13(10):1102-1108. PubMed ID: 28805801
[TBL] [Abstract][Full Text] [Related]
50. CDK8 regulates E2F1 transcriptional activity through S375 phosphorylation.
Zhao J; Ramos R; Demma M
Oncogene; 2013 Jul; 32(30):3520-30. PubMed ID: 22945643
[TBL] [Abstract][Full Text] [Related]
51. CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors.
Xi M; Chen T; Wu C; Gao X; Wu Y; Luo X; Du K; Yu L; Cai T; Shen R; Sun H
Eur J Med Chem; 2019 Feb; 164():77-91. PubMed ID: 30594029
[TBL] [Abstract][Full Text] [Related]
52. A precisely positioned MED12 activation helix stimulates CDK8 kinase activity.
Klatt F; Leitner A; Kim IV; Ho-Xuan H; Schneider EV; Langhammer F; Weinmann R; Müller MR; Huber R; Meister G; Kuhn CD
Proc Natl Acad Sci U S A; 2020 Feb; 117(6):2894-2905. PubMed ID: 31988137
[TBL] [Abstract][Full Text] [Related]
53. Induction of transcription by p21Waf1/Cip1/Sdi1: role of NFkappaB and effect of non-steroidal anti-inflammatory drugs.
Poole JC; Thain A; Perkins ND; Roninson IB
Cell Cycle; 2004 Jul; 3(7):931-40. PubMed ID: 15190207
[TBL] [Abstract][Full Text] [Related]
54. Mediator kinase module and human tumorigenesis.
Clark AD; Oldenbroek M; Boyer TG
Crit Rev Biochem Mol Biol; 2015; 50(5):393-426. PubMed ID: 26182352
[TBL] [Abstract][Full Text] [Related]
55. Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment.
Lin TE; Yang CR; Chou CH; Hsu JY; Chao MW; Sung TY; Hsieh JH; Huang WJ; Hsu KC
Biomed Pharmacother; 2022 Feb; 146():112459. PubMed ID: 34953394
[TBL] [Abstract][Full Text] [Related]
56. CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases.
Liang J; Chen M; Hughes D; Chumanevich AA; Altilia S; Kaza V; Lim CU; Kiaris H; Mythreye K; Pena MM; Broude EV; Roninson IB
Cancer Res; 2018 Dec; 78(23):6594-6606. PubMed ID: 30185549
[TBL] [Abstract][Full Text] [Related]
57. Molecular and
Dannappel MV; Sooraj D; Loh JJ; Firestein R
Front Cell Dev Biol; 2018; 6():171. PubMed ID: 30693281
[TBL] [Abstract][Full Text] [Related]
58. Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19.
Mallinger A; Schiemann K; Rink C; Stieber F; Calderini M; Crumpler S; Stubbs M; Adeniji-Popoola O; Poeschke O; Busch M; Czodrowski P; Musil D; Schwarz D; Ortiz-Ruiz MJ; Schneider R; Thai C; Valenti M; de Haven Brandon A; Burke R; Workman P; Dale T; Wienke D; Clarke PA; Esdar C; Raynaud FI; Eccles SA; Rohdich F; Blagg J
J Med Chem; 2016 Feb; 59(3):1078-101. PubMed ID: 26796641
[TBL] [Abstract][Full Text] [Related]
59. The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function.
Knuesel MT; Meyer KD; Bernecky C; Taatjes DJ
Genes Dev; 2009 Feb; 23(4):439-51. PubMed ID: 19240132
[TBL] [Abstract][Full Text] [Related]
60. The SCF-Fbw7 ubiquitin ligase degrades MED13 and MED13L and regulates CDK8 module association with Mediator.
Davis MA; Larimore EA; Fissel BM; Swanger J; Taatjes DJ; Clurman BE
Genes Dev; 2013 Jan; 27(2):151-6. PubMed ID: 23322298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
